Doxorubicin — Dosing in CKD & Dialysis

Doxorubicin (Antineoplastic): renal dosing adjustments, dialyzability (Low (marginal hemodialysis clearance of doxorubicin and doxorubicinol in 5 hemodialysis patients; Yoshida 1994, PMID 8137454)), and renal-relevant safety risk for CKD and dialysis patients. Educational reference for nephrology pr

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.